◆英語タイトル:Crown Bioscience Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012881
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月27日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Crown Bioscience Inc (Crown Bioscience) is a pharmaceutical company that provides drug discovery and development services. The company offers in vivo and in vitro research reagents. It offers preclinical contract research services in areas of oncology and metabolic disease. Crown Bioscience’s oncology services comprise oncology databases, ex vivo services, human surrogate trials, in vitro services, in vivo services, preclinical formulations, translational research, and drug discovery services. The company provides metabolic disease services such as CVMD databases, and ex vivo services. It has presence in the US, the UK, China and Taiwan. Crown Bioscience is headquartered in Santa Clara, California, the US.
Crown Bioscience Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Crown Bioscience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Crown Bioscience Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Crown Bioscience Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Crown Bioscience Secures US$29 Million In Series C Venture Financing 10
Partnerships 12
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 12
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 13
Equity Offering 14
Crown Bioscience Raises USD20.8 Million in Public Offering of Shares 14
Acquisition 15
Crown Bioscience Acquires PreClinOmics 15
Crown Bioscience Inc – Key Competitors 16
Crown Bioscience Inc – Key Employees 17
Crown Bioscience Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Jul 13, 2017: Crown Bioscience Expands its Life Science Portfolio 19
Jan 26, 2017: CrownBio Announces Expansion of Life Science Division 20
Financial Announcements 21
Aug 10, 2017: Crown Bioscience Announces Second Quarter Results 21
May 19, 2017: Crown Bioscience Announces Record Breaking Growth With First 2017 Quarter Results 22
Corporate Communications 23
Nov 09, 2017: Crown Bioscience Announcing the 2017 Board of Directors Election Results Dr. Guoliang Yu re-elected as the Chairman 23
Sep 27, 2017: Crown Bioscience Names Laurie Heilmann Chief Business Officer; Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the Role 24
Aug 22, 2017: Crown Bioscience Names Dr. Leon Hall Vice President of Global Scientific Excellence 25
Aug 10, 2017: Crown Bioscience Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations 26
Aug 30, 2016: Crown Bioscience Strategically Strengthens Leadership Team and Names New Chief Financial Officer 27
Aug 25, 2016: Crown Bioscience Expands CVMD Leadership Team 28
Product News 29
Jun 01, 2017: Crown Bioscience Showcases Dramatic Proficiency in PDX Models and Emerging Expertise in Immune-Oncology 29
May 24, 2016: Crown Bioscience Launching OncoExpress Technology at American Society of Clinical Oncology Meeting 30
Other Significant Developments 31
Aug 02, 2016: Crown Bioscience Announces the Completion of Over 100 Blood Cancer Studies 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Crown Bioscience Inc, Medical Equipment, Key Facts 2
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Crown Bioscience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Crown Bioscience Inc, Deals By Market, 2011 to YTD 2017 8
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Crown Bioscience Secures US$29 Million In Series C Venture Financing 10
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 12
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 13
Crown Bioscience Raises USD20.8 Million in Public Offering of Shares 14
Crown Bioscience Acquires PreClinOmics 15
Crown Bioscience Inc, Key Competitors 16
Crown Bioscience Inc, Key Employees 17
Crown Bioscience Inc, Other Locations 18
Crown Bioscience Inc, Subsidiaries 18